SEARCH

SEARCH BY CITATION

References

  • Abdelmohsen K., Pullmann R. Jr, Lal A. et al. (2007) Phosphorylation of hur by chk2 regulates sirt1 expression. Mol. Cell 25, 543557.
  • Adibhatla R. M. and Hatcher J. F. (2005) Cytidine 5’-diphosphocholine (cdp-choline) in stroke and other cns disorders. Neurochem. Res. 30, 1523.
  • Andersen M., Overgaard K., Meden P., Boysen G. and Choi S. C. (1999) Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model. Stroke 30, 14641471.
  • Aronowski J., Strong R. and Grotta J. C. (1996) Citicoline for treatment of experimental focal ischemia: histologic and behavioral outcome. Neurol. Res. 18, 570574.
  • Bonda D. J., Lee H. G., Camins A., Pallas M., Casadesus G., Smith M. A. and Zhu X. (2011) The sirtuin pathway in ageing and alzheimer disease: mechanistic and therapeutic considerations. Lancet Neurol. 10, 275279.
  • Bordone L., Motta M. C., Picard F. et al. (2006) Sirt1 regulates insulin secretion by repressing ucp2 in pancreatic beta cells. PLoS Biol. 4, e31.
  • Borra M. T., Smith B. C. and Denu J. M. (2005) Mechanism of human sirt1 activation by resveratrol. J. Biol. Chem. 280, 1718717195.
  • Davalos A. and Secades J. (2011) Citicoline preclinical and clinical update 2009–2010. Stroke 42, S36S39.
  • Davalos A., Castillo J., Alvarez-Sabin J. et al. (2002) Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke 33, 28502857.
  • Davalos A., Alvarez-Sabin J., Castillo J. et al. (2012) Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ictus trial). Lancet 380, 349357.
  • Della-Morte D., Dave K. R., DeFazio R. A., Bao Y. C., Raval A. P. and Perez-Pinzon M. A. (2009) Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience 159, 9931002.
  • Diederich K., Frauenknecht K., Minnerup J., Schneider B. K., Schmidt A., Altach E., Eggert V., Sommer C. J. and Schabitz W. R. (2012) Citicoline enhances neuroregenerative processes after experimental stroke in rats. Stroke 43, 19311940.
  • Donmez G. (2012) The neurobiology of sirtuins and their role in neurodegeneration. Trends Pharmacol. Sci. 33, 494501.
  • Donmez G., Arun A., Chung C. Y., McLean P. J., Lindquist S. and Guarente L. (2012) Sirt1 protects against alpha-synuclein aggregation by activating molecular chaperones. J. Neurosci. 32, 124132.
  • Grozinger C. M., Chao E. D., Blackwell H. E., Moazed D. and Schreiber S. L. (2001) Identification of a class of small molecule inhibitors of the sirtuin family of nad-dependent deacetylases by phenotypic screening. J. Biol. Chem. 276, 3883738843.
  • Haigis M. C. and Sinclair D. A. (2010) Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol. 5, 253295.
  • Hernández-Jiménez M., Hurtado O., Cuartero M. I., Ballesteros I., Moraga A., Pradillo J. M., McBurney M. W., Lizasoain I. and Moro M. A. (2013) Silent information regulator 1 (SIRT1) protects the brain against cerebral ischemic damage. Stroke (in press).
  • Hurtado O., Moro M. A., Cardenas A. et al. (2005) Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport. Neurobiol. Dis. 18, 336345.
  • Hurtado O., Cardenas A., Pradillo J. M., Morales J. R., Ortego F., Sobrino T., Castillo J., Moro M. A. and Lizasoain I. (2007) A chronic treatment with cdp-choline improves functional recovery and increases neuronal plasticity after experimental stroke. Neurobiol. Dis. 26, 105111.
  • Hurtado O., Pradillo J. M., Fernandez-Lopez D., Morales J. R., Sobrino T., Castillo J., Alborch E., Moro M. A. and Lizasoain I. (2008) Delayed post-ischemic administration of cdp-choline increases eaat2 association to lipid rafts and affords neuroprotection in experimental stroke. Neurobiol. Dis. 29, 123131.
  • Hurtado O., Lizasoain I. and Moro M. A. (2011) Neuroprotection and recovery: recent data at the bench on citicoline. Stroke 42, S33S35.
  • Hurtado O., Ballesteros I., Cuartero M. I. et al. (2012) Daidzein has neuroprotective effects through ligand-binding-independent ppargamma activation. Neurochem. Int. 61, 119127.
  • Kakihana M., Fukuda N., Suno M. and Nagaoka A. (1988) Effects of cdp-choline on neurologic deficits and cerebral glucose metabolism in a rat model of cerebral ischemia. Stroke 19, 217222.
  • Kwon H. S. and Ott M. (2008) The ups and downs of sirt1. Trends Biochem. Sci. 33, 517525.
  • Lavu S., Boss O., Elliott P. J. and Lambert P. D. (2008) Sirtuins–novel therapeutic targets to treat age-associated diseases. Nat. Rev. Drug Discovery 7, 841853.
  • McBurney M. W., Yang X., Jardine K., Bieman M., Th'ng J. and Lemieux M. (2003) The absence of sir2alpha protein has no effect on global gene silencing in mouse embryonic stem cells. Mol. Cancer Res. 1, 402409.
  • Milne J. C. and Denu J. M. (2008) The sirtuin family: therapeutic targets to treat diseases of aging. Curr. Opin. Chem. Biol. 12, 1117.
  • Pasinetti G. M., Wang J., Marambaud P., Ferruzzi M., Gregor P., Knable L. A. and Ho L. (2011) Neuroprotective and metabolic effects of resveratrol: Therapeutic implications for huntington's disease and other neurodegenerative disorders. Exp. Neurol. 232, 16.
  • Ramadori G., Lee C. E., Bookout A. L., Lee S., Williams K. W., Anderson J., Elmquist J. K. and Coppari R. (2008) Brain sirt1: anatomical distribution and regulation by energy availability. J. Neurosci. 28, 99899996.
  • Romera C., Hurtado O., Botella S. H., Lizasoain I., Cardenas A., Fernandez-Tome P., Leza J. C., Lorenzo P. and Moro M. A. (2004) In vitro ischemic tolerance involves upregulation of glutamate transport partly mediated by the tace/adam17-tumor necrosis factor-alpha pathway. J. Neurosci. 24, 13501357.
  • Sobrado M., Pereira M. P., Ballesteros I. et al. (2009) Synthesis of lipoxin a4 by 5-lipoxygenase mediates ppargamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke. J. Neurosci. 29, 38753884.
  • Vang O., Ahmad N., Baile C. A. et al. (2011) What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS ONE 6, e19881.
  • Wang P., Xu T. Y., Guan Y. F., Tian W. W., Viollet B., Rui Y. C., Zhai Q. W., Su D. F. and Miao C. Y. (2011) Nicotinamide phosphoribosyltransferase protects against ischemic stroke through sirt1-dependent adenosine monophosphate-activated kinase pathway. Ann. Neurol. 69, 360374.
  • Zhu H. R., Wang Z. Y., Zhu X. L., Wu X. X., Li E. G. and Xu Y. (2010) Icariin protects against brain injury by enhancing sirt1-dependent pgc-1alpha expression in experimental stroke. Neuropharmacology 59, 7076.